newsfilter
← Latest News
ACCESS Newswire·

XPhyto Signs Letter of Intent for US Manufacturing and Strategic Business Opportunities

VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / October 4, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to report that it has signed a non-binding Letter of Intent ("LOI") to identify and